BIBW2992 (Afatinib)
Catalog No. A10141
BIBW2992 (Afatinib)是酪氨酸激酶抑制剂(TKI),它不可逆地抑制人表皮生长因子受体2(Her2)和表皮生长因子受体(EGFR)激酶。
- Aya Hasan Alshammari, .et al. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition, Biochem Pharmacol, 2022, Mar;197:114914 PMID: 35041812
- Van Sebille YZ, .et al. Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity, Exp Biol Med (Maywood), 2019, Jun 11:1535370219855334 PMID: 31184924
- Fujita KI, .et al. Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites, J Pharm Sci, 2017, Sep;106(9):2632-2641 PMID: 28479358
Catalog Num | A10141 |
---|---|
M. Wt | 485.9 |
Formula | C24H25ClFN5O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 439081-18-2 |
Synonyms | Tomtovok,Afatinib |
SMILES | CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4 |
BIBW2992 (Afatinib)是酪氨酸激酶抑制剂(TKI),它不可逆地抑制人表皮生长因子受体2(Her2)和表皮生长因子受体(EGFR)激酶。
Targets
EGFR (L858R) (Cell-free assay) | EGFR (wt) (Cell-free assay) | EGFR (L858R/T790M) (Cell-free assay) | HER2 (Cell-free assay) | |
0.4 nM | 0.5 nM | 10 nM | 14 nM |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.58 mL | 102.9 mL | 205.8 mL |
0.5 mM | 4.12 mL | 20.58 mL | 41.16 mL |
1 mM | 2.06 mL | 10.29 mL | 20.58 mL |
5 mM | 0.41 mL | 2.06 mL | 4.12 mL |
*The above data is based on the productmolecular weight 485.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.